JAMES PETER HANSEN
Allopathic & Osteopathic Physicians|Internal Medicine SAN FRANCISCO, CA NPI 1720198203
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Lilly USA, LLC All categories
General Payments — all program years on this page
$4,154.86
- Category: General Payments
- Program years: PY2018–2024
- Record count: 154
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,377.62 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,377.62 | 62 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $263.06 | 8 |
| ABBVIE INC. | $210.15 | 8 |
| Novo Nordisk AS | $206.96 | 16 |
| PFIZER INC. | $146.58 | 8 |
| Otsuka America Pharmaceutical, Inc. | $82.35 | 3 |
| Amgen Inc. | $71.92 | 3 |
| Teva Pharmaceuticals USA, Inc. | $44.08 | 2 |
| Neurocrine BioSciences, Inc. | $32.84 | 1 |
| Astellas Pharma US Inc | $32.75 | 1 |
| Acerta Pharma LLC | $31.98 | 1 |
| E.R. Squibb & Sons, L.L.C. | $31.23 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.00 | 2 |
| Lundbeck LLC | $30.82 | 1 |
| EMD Serono, Inc. | $28.14 | 1 |
| Lexicon Pharmaceuticals, Inc. | $27.23 | 1 |
| Edwards Lifesciences Corporation | $24.37 | 1 |
| DEXCOM, INC. | $23.32 | 1 |
| GlaxoSmithKline, LLC. | $21.36 | 1 |
| Kowa Pharmaceuticals America, Inc. | $18.75 | 1 |
| Exact Sciences Corporation | $18.73 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.